AllianceBernstein’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$452K Hold
40,020
﹤0.01% 2702
2025
Q1
$462K Hold
40,020
﹤0.01% 2588
2024
Q4
$339K Hold
40,020
﹤0.01% 2810
2024
Q3
$463K Sell
40,020
-2,430
-6% -$28.1K ﹤0.01% 2692
2024
Q2
$500K Buy
42,450
+12,440
+41% +$147K ﹤0.01% 2667
2024
Q1
$356K Hold
30,010
﹤0.01% 2740
2023
Q4
$368K Sell
30,010
-2,400
-7% -$29.4K ﹤0.01% 2758
2023
Q3
$312K Hold
32,410
﹤0.01% 2782
2023
Q2
$292K Buy
32,410
+6,710
+26% +$60.4K ﹤0.01% 2872
2023
Q1
$202K Hold
25,700
﹤0.01% 2903
2022
Q4
$174K Buy
25,700
+8,636
+51% +$58.4K ﹤0.01% 3034
2022
Q3
$248K Buy
17,064
+1,964
+13% +$28.5K ﹤0.01% 2939
2022
Q2
$149K Buy
15,100
+4,700
+45% +$46.4K ﹤0.01% 3070
2022
Q1
$153K Sell
10,400
-1,800
-15% -$26.5K ﹤0.01% 3039
2021
Q4
$161K Hold
12,200
﹤0.01% 3117
2021
Q3
$213K Hold
12,200
﹤0.01% 3060
2021
Q2
$292K Buy
+12,200
New +$292K ﹤0.01% 3006
2021
Q1
Sell
-18,800
Closed -$357K 3253
2020
Q4
$357K Sell
18,800
-900
-5% -$17.1K ﹤0.01% 2759
2020
Q3
$248K Hold
19,700
﹤0.01% 2885
2020
Q2
$238K Buy
19,700
+7,400
+60% +$89.4K ﹤0.01% 2947
2020
Q1
$94K Buy
12,300
+2,200
+22% +$16.8K ﹤0.01% 2963
2019
Q4
$180K Hold
10,100
﹤0.01% 2936
2019
Q3
$117K Buy
+10,100
New +$117K ﹤0.01% 3040